Wright Lassiter III - Apr 1, 2025 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Role: Director
Signature: Sean D. Mersten, Attorney in Fact for Wright L. Lassiter, III
Stock symbol: DGX
Transactions as of: Apr 1, 2025
Transactions value $: $0
Form type: 4
Date filed: 4/3/2025, 04:40 PM
Previous filing: Mar 31, 2025
Next filing: May 19, 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DGX	Phantom Stock Units	Award	$0	+169	+88.52%	$0.00	360	Apr 1, 2025	Common Stock	169	$0.00	Direct	F1, F2

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.
F2	Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11.